NEUROENDOCRINE TUMORS OF THE STOMACH: CLASSIFICATION, DIAGNOSTICS, TREATMENT (LITERATURE REVIEW)


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Neuroendocrine tumors (NET) of the stomach constitute 3-6% of NEO and about 2% of all gastric tumors. NEO of the stomach - a heterogeneous group, including both highly differentiated tumors amenable to endoscopic treatment and characterized by a favorable prognosis, and highly malignant poorly differentiated tumors possessing high metastatic potential and characterized by an extremely aggressive course and poor prognosis. Modern classification of NEO of the stomach is presented; the basic methods of their diagnosis are discussed. It emphasized the treatment of patients with NETs of the stomach can vary from minimally invasive endoscopic techniques (type I and II carcinoids) to aggressive programs of combined and complex treatment (neuroendocrine carcinoid G3).

全文:

受限制的访问

作者简介

V. Khomyakov

Email: vladimirkhom@mail.rn
MSROI n.a. P.A. Herzen - Branch of the FSBI NMRRC of RMH PhD, Head of Thoracoabdominal Department Moscow

S. Pirogov

MSROI n.a. P.A. Herzen - Branch of the FSBI NMRRC of RMH Moscow

A. Ivanov

MSROI n.a. P.A. Herzen - Branch of the FSBI NMRRC of RMH Moscow

参考

  1. Янкин А.В. Нейроэндокринные опухоли желудочно-кишечного тракта. Практическая онкология. 2005:6(4):227-33.
  2. Modlin I.M., Lye K.D., Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934-59.
  3. Landry C.S., Brock G., Scoggins C.R., McMasters K.M., Martin R.C. 2nd. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann. Surg. Oncol. 2009;16(1):51-60.
  4. Mulkeen A., Cha С. Gastric carcinoid. Curr. Opin. Oncol. 2005;17(1):1-6.
  5. Modlin I.M., Oberg K., Chung D.C., Jensen R.T., de Herder W.W., Thakker R.V., Caplin M., Delle Fave G., Kaltsas G.A., Krenning E.P., Moss S.F., Nilsson O., Rindi G., Salazar R., Ruszniewski P., Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61-72.
  6. Burkitt M.D., Pritchard D.M. Pathogenesis and management of gastric carcinoid tumours. Aliment. Pharmacol. Ther. 2006;24(9):1305-20.
  7. Hodgson N., Koniaris L.G., Livingstone A.S., Franceschi D. Gastric carcinoids: a temporal increase with proton pump introduction. Surg. Endosc. 2005;19(12):1610-12.
  8. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion. 1986;35(Suppl 1):42-55.
  9. Kloppel G. Oberndorfer and his successors: from carcinoid to neuroendocrine carcinoma. Endocr. Pathol. 2007;18(3):141-44.
  10. Rindi G., Klöppel G., Alhman H., Caplin M., Couvelard A., de Herder W.W., Erikssson B., Falchetti A., Falconi M., Komminoth P., Körner M., Lopes J.M., McNicol A.M., Nilsson O., Perren A., Scarpa A., Scoazec J.Y., Wiedenmann B.; all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449(4):395-401.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##